Oxytocin Boosts Social Behavior Only With Motivation

Summary: A recent study shows that oxytocin’s effect on social behavior depends strongly on the recipient’s current social motivation. In rhesus macaques, oxytocin enhanced and prolonged prosocial choices only when animals were already inclined to engage socially. When motivation was low, the hormone had little measurable impact.

Neural recordings linked these behavioral effects to increased activity and tighter coordination between the basolateral amygdala (BLA) and the anterior cingulate cortex (ACC) during motivated social states. These results help explain inconsistent clinical outcomes with oxytocin treatments and point toward the value of tailoring interventions to an individual’s momentary social motivation.

Key Facts

  • State-Dependent Effects: Oxytocin supported prosocial choices only when animals were already socially motivated.
  • Neural Coordination: Enhanced activity in the BLA and ACC and stronger BLA–ACC communication accompanied sustained social engagement.
  • Clinical Implications: Findings suggest oxytocin-based therapies may be more effective if aligned with a patient’s current social drive and context.

Source: SfN

Background: Oxytocin is widely studied for its role in promoting social bonding and prosocial behaviors, and it has been investigated as a potential treatment to improve social functioning in conditions such as autism. However, clinical trials have produced mixed results, with substantial variability across participants and studies.

To better understand why outcomes vary, Steve Chang and colleagues at Yale University examined how oxytocin modifies brain activity to shape social decision-making in male rhesus macaques. They focused on two brain regions known to influence social valuation and choice: the basolateral amygdala, which signals social salience and reward value, and the anterior cingulate cortex, which integrates social information to guide decisions.

This shows two people with brain overlays.
The researchers focused on the basolateral amygdala (BLA) and the anterior cingulate cortex (ACC) because these brain areas process reward and integrate information during social decision-making. Credit: Neuroscience News

The team tested the behavioral and neural effects of directly infusing oxytocin into the BLA (Oxt-BLA), comparing those effects with saline controls. Across sessions, they categorized trials based on the monkeys’ baseline prosocial state—either high prosocial motivation or low prosocial motivation—and measured both choices in social tasks and neural activity in BLA and ACC.

Behaviorally, oxytocin in the BLA sustained prosocial choices and kept animals engaged in social tasks during high-motivation states, effectively countering the natural decline in social responsiveness seen under control conditions. In contrast, when monkeys began in a low prosocial state, Oxt-BLA produced little to no change in social choices or task engagement.

At the neural level, the presence of oxytocin increased activity in both the BLA and ACC specifically during high prosocial states. Moreover, oxytocin preserved coordination between these regions: BLA–ACC communication remained stable over time in motivated sessions, whereas coordination tended to decline in saline controls. This sustained interregional signaling provides a plausible circuit mechanism by which oxytocin prolongs prosocial behavior when motivation is already present.

As Chang notes, previous work highlighted the importance of BLA–ACC communication for social reward and behavior; the current study links enhancement of that signal with more persistent prosocial actions. The state-dependent nature of the effect suggests oxytocin does not uniformly elevate social behavior but instead amplifies existing social intent by stabilizing relevant neural circuits.

Clinically, these findings underline the need for individualized and context-aware approaches when considering oxytocin as a therapeutic tool. Rather than applying a standardized regimen across patients and situations, effective interventions may require assessing and aligning treatment with a person’s social motivation or using strategies that boost motivation alongside neuromodulation.

About this social neuroscience research news

Author: SfN Media
Source: SfN
Contact: SfN Media – SfN
Image: The image is credited to Neuroscience News

Original Research: Closed access.
“Oxytocin in the Amygdala Sustains Prosocial Behavior via State-Dependent Amygdala-Prefrontal Modulation” by Steve Chang et al., Journal of Neuroscience.


Abstract

Oxytocin in the Amygdala Sustains Prosocial Behavior via State-Dependent Amygdala-Prefrontal Modulation

Prosocial behaviors are essential for maintaining complex primate social networks. The basolateral amygdala (BLA) evaluates social salience and value, while the anterior cingulate cortex (ACCg) integrates social information to guide choices. Oxytocin is a neuromodulator implicated in social behavior and neural activity within these regions, but its precise circuit-level effects have been unclear.

This study infused oxytocin or saline into the BLA and measured its effects on prosocial decisions, local BLA activity, ACCg responses, and coordination between the two areas in male rhesus macaques. Results showed that oxytocin’s behavioral and neural effects were state-dependent: during high prosocial states, oxytocin sustained prosocial choices, boosted BLA and ACCg activity associated with those choices, and maintained stable BLA–ACCg coordination. During low prosocial states, oxytocin had minimal effects.

The findings indicate that oxytocin acts as a state-dependent modulator in the BLA, enhancing BLA and ACCg responses and preserving interregional communication to support prosocial decision-making when social motivation is present.